Detalhe da pesquisa
1.
Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.
N Engl J Med
; 389(1): 33-44, 2023 Jul 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37407001
2.
Mechanisms of Resistance to Noncovalent Bruton's Tyrosine Kinase Inhibitors.
N Engl J Med
; 386(8): 735-743, 2022 02 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196427
3.
Clonal Hematopoiesis and the Heart: a Toxic Relationship.
Curr Oncol Rep
; 25(5): 455-463, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36920637
4.
Prostate cancer research in the 21st century; report from the 2021 Coffey-Holden prostate cancer academy meeting.
Prostate
; 82(2): 169-181, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34734426
5.
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study.
Lancet
; 397(10277): 892-901, 2021 03 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33676628
6.
Genomic characteristics and prognostic significance of co-mutated ASXL1/SRSF2 acute myeloid leukemia.
Am J Hematol
; 96(4): 462-470, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502020
7.
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
Br J Haematol
; 188(6): 918-923, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682002
8.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
9.
Noncovalent BTK inhibitors in B-cell lymphoma.
Clin Adv Hematol Oncol
; 21(2): 100-103, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36780476
10.
Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukaemia.
Haematologica
; 106(1): 284-287, 2021 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32079693
11.
Venetoclax-induced tumour lysis syndrome in acute myeloid leukaemia.
Br J Haematol
; 188(1): 173-177, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31621058
12.
Enasidenib-induced eosinophilic differentiation in a patient with acute myeloid leukaemia with IDH2 and U2AF1 mutations.
Br J Haematol
; 184(4): 496, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30334576
13.
Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans.
Blood
; 120(8): 1687-90, 2012 Aug 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-22745306
14.
Frontline Therapy of CLL-Changing Treatment Paradigms.
Curr Hematol Malig Rep
; 19(2): 65-74, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38337108
15.
Are we closer to a standard of care for Richter's syndrome? Novel treatments on the horizon.
Expert Rev Hematol
; : 1-10, 2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38693662
16.
Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms.
Leuk Lymphoma
; 65(2): 209-218, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37921062
17.
Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia: joint experience of the MD Anderson Cancer Center and Duke University Medical Center.
Cancer
; 119(17): 3177-85, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24022787
18.
Acute promyelocytic leukemia and chronic lymphocytic leukemia diagnosed concurrently.
Am J Hematol
; 93(4): 595-596, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-29052253
19.
SOHO State of the Art Updates and Next Questions: Updates on BTK Inhibitors for the Treatment of Chronic Lymphocytic Leukemia.
Clin Lymphoma Myeloma Leuk
; 23(10): 697-704, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37544810
20.
Cellular Therapies in Chronic Lymphocytic Leukemia and Richter's Transformation: Recent Developments in Chimeric Antigen Receptor T-Cells, Natural Killer Cells, and Allogeneic Stem Cell Transplant.
Cancers (Basel)
; 15(6)2023 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36980726